Table 1 Demographic and Clinical Characteristics.
All patients | 273 |
Median age(range), years | 54(50–66) |
Gender, n (%) | |
Male | 165(60.4%) |
Female | 108(39.6%) |
Diagnosis, n (%) | |
AML | 124(45.4%) |
ALL | 47(17.2%) |
MDS | 66(24.2%) |
CMML | 10(3.7%) |
Others | 26(9.5%) |
Number of pregnancies, n (%) | |
0 | 168(61.5%) |
1 | 61(22.3%) |
≥2 | 44(16.1%) |
Number of transfusions, n (%) | |
≤12 | 212(77.7%) |
>12 | 61(22.3%) |
Number of RBC transfusion, n (%) | |
≤7 | 212(77.7%) |
>7 | 61(22.3%) |
Number of platelet transfusion, n (%) | |
≤7 | 226(82.8%) |
>7 | 47(17.2%) |
Course, n (%) | |
≤7.5 | 169(61.9%) |
>7.5 | 104(38.1%) |
PRA | |
Class I (+), n (%) | 73(26.7%) |
Class II (+), n (%) | 38(13.9%) |
Class I and II positive, n (%) | 32(11.7%) |
Class I or II positive, n (%) | 79(28.9%) |
Anti-HLA antibodies against single locus positive | 79(28.9%) |
Median MFI (range) | |
Class I (+) | 2902(558–22827) |
Class II (+) | 4332(516–18363) |
